Clinical Trial Update: Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and effects of Vorapaxar in Japanese subjects with acute coronary syndrome. The study reported results in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Syndrome
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Vorapaxar (Zontivity) (vorapaxar)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Atherosclerosis, Myocardial Ischemia | Phase 2 | Status: COMPLETED | Results posted: 2014-08-15